N/A N=1,915 Genetics of Diabetes Audit and Research in Tayside Scotland (DOLORisk Dundee)
Diabetic Neuropathic Pain
Primary: Neuropathic Pain — 482; 461; 560 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=57 Estrogen and Diabetes
Diabetes Mellitus, Type 1
Primary: FMD/Shear — 0.182; 0.206; 0.155; 0.219 %/s^-1
N/A N=14 The Effect of Hypoxia on Type 2 Diabetes and Weight Loss
Type2 Diabetes
Primary: Δ Mean AUC (Area Under the Curve) Plasma [Glucose] — -17.7; 54.9 mmol.min.L-1
N/A N=58 Delish Study: Diabetes Education to Lower Insulin, Sugars, and Hunger
Diabetes Mellitus, Type 2
Primary: Frequency of Eating in Response to Cravings (Primary Mechanistic Outcome) — -20.39; -25.27 % of EMAs with craving related eating
N/A N=78 Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DM
Diabetes Mellitus, Type II
Primary: Percent Change in Plasma Triglycerides — -2.0; 16.0; -5.0; -5.0 percent change
N/A N=30 Model Driven Diabetes Care
Diabetes Mellitus, Type 1
Primary: Change in the Frequency of Hyper- and Hypo-glycemic Events From Baseline to Week 8-12. — -18; -7.5 Events
N/A N=1,369 Computer Automation for Diagnosis and Management of Childhood Type 2 Diabetes
Type 2 Diabetes
Primary: Number of Children With Documented Risk Factors for Type 2 Diabetes — 283; 282 Participants
N/A N=13 Dark Chocolate and Glucose Levels in Diabetes
Type 2 Diabetes · Type 1 Diabetes
Primary: Blood Glucose Incremental Area Under the Curve — 240.5; 83.81 mM x 120 minutes
N/A N=176 Cooking for Health
Diabetes Mellitus, Type 2
Primary: Change (From Baseline) in Self-reported Intake (Servings/Day) of Sugar-sweetened Beverages (Measured Using the Nutrition Assessment Shared Resource Food Frequency…
Phase 3 N=127 Vitamin D for Established Type 2 Diabetes (DDM2)
Type 2 Diabetes
Primary: Disposition Index — 0.023; 0.149 index
N/A N=177 Diabetes and Lipid Accumulationand Heart Transplant
Diabetes Mellitus · Heart Failure
Primary: Myocyte Lipid Accumulation as Oil Red-O Positive Biopsie — 54; 21; 0 Endomyocardial Biopsies
N/A N=17 Insulin Secretion in Diabetes Before and After Glycemic Control
Diabetes · Hyperglycemia
Primary: ISR in Response to a Glucose Clamp and Oral Glucose Ingestion Before and After 2 Months of Insulin Treatment to Improve Average Glycemia. — 0.67; 0.75; 1.11; 0.76 pmol/min
N/A N=235 Type 2 Diabetes Exemplar: A Remote Care Service for North West London
Type 2 Diabetes Mellitus
Primary: % Participants Downloading Huma App — 95; 0 Participants
N/A N=958 Gestational Diabetes Mellitus Trial (GDM)
Diabetes, Gestational
Primary: Number of Participants With Composite Neonatal Morbidity — 149; 163; 62; 55 Participants — p=0.14
N/A N=115 Precision Diets for Diabetes Prevention
Pre Diabetes · Insulin Resistance · Diabetes Mellitus, Type 2
Primary: Change in Glycemic Control as Measured by Change Blood Sugar Values — 88.9; 95.4; 90.8; 96.7 mg/dL — p=<0.001
Phase 4 N=150 Diabetes in the Elderly: Prospective Study
Diabetes · Hyperglycemia
Primary: Percent of Participants With a Mean Blood Glucose Concentration of Less Than 70 mg/dL — 28; 31 percentage of participants
N/A N=65 CTSI Pilot: Improving Adherence to Diabetic Diet
Diabetes Mellitus, Type 2 · Diet, Healthy · Pre-diabetes
Primary: Calories Purchased — 24443.30; 25339.20; 18527.35 Kcal
N/A N=34 Effect of Whole Fruit on Glycemic Control in Adults With Type 2 Diabetes
Diabetes Mellitus, Type 2
Primary: Diabetes Remission Rate — 3; 6 Participants — p=<0.0001
Phase 4 N=36 Sitagliptin + Metformin Compared to Metformin Monotherapy and Placebo in Women With a Recent GDM
Disorder of Glucose Regulation
Primary: Normalization of Glucose Levels — 9; 2; 4 Participants — p=.035
N/A N=55 Type 2 Diabetes and Exercise Function in Single Leg Exercises
Type 2 Diabetes
Primary: Change in Muscle Oxygen Saturation — -10.7127; -8.9149; -12.471; -8.7883 percentage
Phase 2 N=30 Effect of Gymnema Sylvestre on Patients With Impaired Glucose Tolerance.
Impaired Glucose Tolerance
Primary: Fasting Plasma Glucose — 77.4; 77.7 mmol/L
N/A N=110 Managing Diabetes to Gain Opportunities for a More Active Life
Diabetes Mellitus, Type 2
Primary: Documentation of Diabetes Goal — 21; 27; 29; 23 Participants — p=<0.01
N/A N=512 My Diabetes, My Community
Type 2 Diabetes
Primary: Mean Change in Percent of Hemoglobin A1C — -1.1; -0.8; -0.8 percentage of hemoglobin A1C — p=0.8
N/A N=32 Insulin Sensitivity in Patients With Atopic Dermatitis
Atopic Dermatitis/Eczema · Type 2 Diabetes
Primary: Insulin Sensitivity Difference Between Patients With Atopic Dermatitis and Controls — 9.8; 9.2 mg glucose/kg body mass/minute
N/A N=62 Effects of Micronutrient (Chromium) Supplementation on Diabetes
Diabetes Mellitus, Type 1
Primary: Blood Glucose Level — 172.39; 212.85; 164.47; 191.25 mg/dL
N/A N=35 Resolution of Type 2 Diabetes Mellitus: Intensive vs. Conventional Glycaemic Control After Obesity Surgery
Type 2 Diabetes Mellitus · Obesity
Primary: Percentage of Patients With Type 2 Diabetes Mellitus Who Achieve Fasting Blood Glucose of Less Than 5.6 mmol/l and/or HbA1c of Less Than 6% — 4; 4 Participants
N/A N=73 Metabolic Characteristics of Lean Diabetes in Rural and Semi-urban India and in the United States
Malnutrition; Diabetes · Diabetes
Primary: Endogenous Glucose Production — 0.5; 0.84; 0.6; 0.4 mg/kg/min
N/A N=64 TRE in Type 2 Diabetes (See Food Study 3)
Type2Diabetes
Primary: Change in Glycemic Measures- HbA1c (12w) — -0.22; -0.25 percentage of glycated hemoglobin
N/A N=187 Abnormal Blood Sugar Tests in Diabetic Patients During Colonoscopy Preparation
Type 2 Diabetes Mellitus · Colonoscopy
Primary: Abnormal Glucose Levels After Colonoscopic Preparation — 2; 0; 185 Participants
N/A N=24 Digital Exercise for Middle-Aged Adults With Type 1 Diabetes and Other Absolute Insulin Deficiency Diabetes
Type 1 Diabetes · Latent Autoimmune Diabetes in Adults · Pancreatitis
Primary: Feasibility of Usage — 168 minutes/week